AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand · Delayed Price · Currency is NZD 3.520
-0.110 (-3.03%)
At close: Nov 28, 2025
AFT Pharmaceuticals Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 17.14 | 11.96 | 15.61 | 10.65 | 19.85 | 7.78 | Upgrade |
Depreciation & Amortization | 1.88 | 1.2 | 1.2 | 0.85 | 0.91 | 0.98 | Upgrade |
Other Amortization | 1.47 | 1.47 | 0.81 | 0.88 | 0.13 | 0.13 | Upgrade |
Loss (Gain) From Sale of Assets | 0.23 | 0.23 | 0.57 | 0.53 | - | - | Upgrade |
Stock-Based Compensation | -0.01 | 0.04 | 0.14 | - | 0.01 | 0.04 | Upgrade |
Other Operating Activities | 3.2 | 4.74 | 9.03 | 5.67 | 0.72 | 3.46 | Upgrade |
Change in Accounts Receivable | -8.95 | -4.34 | 2.5 | -10.72 | -4.96 | -4.56 | Upgrade |
Change in Inventory | -9.97 | 0.58 | -6.66 | -8.9 | 0.15 | -10.92 | Upgrade |
Change in Accounts Payable | 4.3 | -2.7 | 5.67 | 12.67 | -2.66 | 3.84 | Upgrade |
Operating Cash Flow | 9.3 | 13.18 | 28.86 | 11.63 | 14.15 | 0.75 | Upgrade |
Operating Cash Flow Growth | -63.88% | -54.35% | 148.18% | -17.83% | 1786.93% | -94.96% | Upgrade |
Capital Expenditures | -0.2 | -0.28 | -0.12 | -0.2 | -0.33 | -0.09 | Upgrade |
Sale (Purchase) of Intangibles | -6.31 | -6.67 | -9.41 | -8.98 | -5.26 | -6.14 | Upgrade |
Investing Cash Flow | -6.51 | -6.95 | -9.53 | -9.18 | -5.59 | -6.23 | Upgrade |
Short-Term Debt Issued | - | 1.08 | - | - | - | 1.64 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 5 | - | Upgrade |
Total Debt Issued | 5.82 | 1.08 | - | - | 5 | 1.64 | Upgrade |
Long-Term Debt Repaid | - | -3.42 | -5.86 | -4.59 | -5.38 | -7.13 | Upgrade |
Net Debt Issued (Repaid) | 2.4 | -2.34 | -5.86 | -4.59 | -0.38 | -5.49 | Upgrade |
Issuance of Common Stock | - | - | - | 0.48 | 0.3 | 12.4 | Upgrade |
Preferred Dividends Paid | - | - | - | - | - | -0.19 | Upgrade |
Common Dividends Paid | -1.89 | -1.68 | -1.15 | - | - | - | Upgrade |
Dividends Paid | -1.89 | -1.68 | -1.15 | - | - | -0.19 | Upgrade |
Other Financing Activities | -2.69 | -2.8 | -3.62 | -2.86 | -2.19 | -4.19 | Upgrade |
Financing Cash Flow | -2.18 | -6.81 | -10.63 | -6.98 | -2.28 | 2.52 | Upgrade |
Foreign Exchange Rate Adjustments | -0.09 | -0.34 | 0.05 | -0.12 | 0.1 | 0.05 | Upgrade |
Net Cash Flow | 0.53 | -0.93 | 8.75 | -4.65 | 6.39 | -2.91 | Upgrade |
Free Cash Flow | 9.1 | 12.9 | 28.75 | 11.43 | 13.82 | 0.66 | Upgrade |
Free Cash Flow Growth | -64.38% | -55.14% | 151.44% | -17.30% | 2003.96% | -95.56% | Upgrade |
Free Cash Flow Margin | 3.85% | 6.20% | 14.71% | 7.30% | 10.61% | 0.58% | Upgrade |
Free Cash Flow Per Share | 0.09 | 0.12 | 0.27 | 0.11 | 0.13 | 0.01 | Upgrade |
Cash Interest Paid | 2.82 | 2.82 | 3.69 | 2.87 | 2.2 | 3.48 | Upgrade |
Cash Income Tax Paid | 2.21 | 2.21 | 1.22 | 1.34 | 0.22 | 0.17 | Upgrade |
Levered Free Cash Flow | -3.44 | -2.35 | 10.16 | -4.97 | -0.03 | -12.29 | Upgrade |
Unlevered Free Cash Flow | -1.76 | -0.58 | 12.46 | -3.17 | 1.49 | -10.14 | Upgrade |
Change in Working Capital | -14.62 | -6.46 | 1.5 | -6.95 | -7.47 | -11.64 | Upgrade |
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.